Trial Profile
A retrospective study evaluating efficacy and safety of intravitreal implant of dexamethasone (Ozurdex) in diabetic macular edema in real-life practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema
- Focus Adverse reactions; Therapeutic Use
- 10 Oct 2017 New trial record